Arrowhead Teeing Up Drug Trials
LA500 2024: Christopher Anzalone
Arrowhead Drugs Progress
LA500 2023: Christopher Anzalone
Arrowhead Pharmaceuticals Receives $25M Payment
LABJ Stock Index: November 4
HEALTHCARE: Delhommeau & Williams
ACCOUNTING: Reigstad
SCAN Seeks Disney Magic with New Hire
New Social Club Debuts in Beverly Hills